Text and Data Mining valid from 2020-02-01
Received: 30 October 2018
Accepted: 16 December 2019
First Online: 12 February 2020
: B.J. and J.A.M. are consultants to Celimmune and Bionix. C.K. is a member of the Board of Directors of Protagonist Therapeutics. All other authors declare no competing interests.